Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. August 2025 04:03 ET | Quelle: Research and Markets

United States Narcolepsy Drugs Market to Reach US$ 2,233.56 Million by 2033 - 7.88% CAGR Driven by Novel Therapies and Better Diagnosis

Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "United States Narcolepsy Drugs Market to Reach US$ 2,233.56 Million by 2033 - 7.88% CAGR Driven by Novel Therapies and Better Diagnosis" report has...
18. Juni 2025 06:54 ET | Quelle: Research and Markets

Narcolepsy Therapeutics Competitive Landscape 2025: 735,082 Diagnosed Cases in 2024 Projected to Rise to 761,297 by 2029

Dublin, June 18, 2025 (GLOBE NEWSWIRE) -- The "Narcolepsy: Market View" report has been added to ResearchAndMarkets.com's offering. The Narcolepsy Therapeutics: Competitive Landscape combines...
10. Oktober 2022 05:23 ET | Quelle: Research and Markets

$4.5 Billion Worldwide Narcolepsy Drugs Industry to 2027 - Featuring Avadel Pharmaceuticals, Axsome Therapeutics, Bioprojet Pharma and Graymark Healthcare Among Others

Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
19. Februar 2021 04:23 ET | Quelle: Research and Markets

World Narcolepsy Market Outlook to 2030 - Emerging Drugs and Other Promising Candidates

Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "Narcolepsy Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. The Narcolepsy...